Most bought healthcare stocks in Q4 2020
See which Healthcare stocks institutional investors increased the most in Q4 2020, measured as net growth in reported share positions from Q3 2020 into Q4 2020. Notable additions at the top of this list include ABCELLERA BIOLOGICS INC (ABCL), VIATRIS INC (VTRS), BOSTON SCIENTIFIC CORP (BSX), AVANTOR INC (AVTR). These rankings are based on SEC 13F filings from the investors we track.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| ABCL | ABCELLERA BIOLOGICS INC | 19,283,744 | $775.98K | 1 | 0 | 0 | 0 | 1 |
| VTRS | VIATRIS INC | 17,278,782 | $2.08M | 5 | 0 | 0 | 0 | 5 |
| BSX | BOSTON SCIENTIFIC CORP | 13,139,867 | $427.73K | 1 | 1 | 1 | 1 | 3 |
| AVTR | AVANTOR INC | 9,516,697 | $358.76K | 0 | 2 | 1 | 0 | 3 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 7,394,514 | $449.64K | 0 | 1 | 0 | 0 | 1 |
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 7,369,508 | $137.14K | 0 | 2 | 1 | 0 | 3 |
| FOLD | AMICUS THERAPEUTICS INC | 6,678,788 | $154.21K | 1 | 0 | 0 | 0 | 1 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 5,704,141 | $539.49K | 0 | 1 | 1 | 0 | 2 |
| MRK | MERCK & CO. INC. | 5,515,122 | $422.00K | 1 | 6 | 5 | 1 | 14 |
| RHHBY | ROCHE HOLDINGS LTD-SPONS ADR | 5,357,003 | $234.85K | 1 | 0 | 0 | 0 | 1 |
| TDOC | TELADOC HEALTH INC | 5,207,892 | $989.51K | 0 | 2 | 1 | 0 | 3 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 3,937,914 | $163.23K | 1 | 0 | 0 | 0 | 1 |
| GILD | GILEAD SCIENCES INC | 3,608,539 | $78.18K | 0 | 6 | 3 | 0 | 9 |
| PSNL | PERSONALIS INC | 3,471,682 | $176.50K | 0 | 1 | 0 | 1 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3,406,320 | $391.30K | 0 | 2 | 1 | 0 | 3 |
| BHC | BAUSCH HEALTH COS INC | 3,400,087 | $211.73K | 1 | 2 | 1 | 0 | 5 |
| SDGR | SCHRODINGER INC | 2,804,391 | $398.54K | 0 | 2 | 0 | 1 | 2 |
| TWST | TWIST BIOSCIENCE CORP | 2,716,493 | $590.25K | 0 | 1 | 0 | 0 | 1 |
| CDXS | CODEXIS INC | 2,549,807 | $69.91K | 0 | 1 | 0 | 0 | 1 |
| CLLS | CELLECTIS - ADR | 2,543,994 | $104.24K | 0 | 1 | 0 | 0 | 1 |
| FATE | FATE THERAPEUTICS INC | 2,293,777 | $284.58K | 1 | 1 | 0 | 1 | 2 |
| EXAS | EXACT SCIENCES CORP | 2,194,364 | $418.98K | 0 | 2 | 1 | 1 | 3 |
| ACCD | ACCOLADE INC | 2,124,720 | $96.56K | 0 | 2 | 0 | 0 | 2 |
| CDNA | CAREDX INC | 2,032,695 | $217.31K | 0 | 1 | 0 | 1 | 1 |
| VCYT | VERACYTE INC | 2,009,057 | $213.78K | 0 | 1 | 0 | 0 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 1,876,764 | $346.75K | 2 | 2 | 4 | 0 | 8 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,861,422 | $50.73K | 1 | 0 | 0 | 0 | 1 |
| HCA | HCA HEALTHCARE INC | 1,806,225 | $428.78K | 2 | 1 | 1 | 0 | 4 |
| MRNA | MODERNA INC | 1,752,724 | $183.11K | 1 | 0 | 0 | 0 | 1 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | 1,746,288 | $59.25K | 0 | 2 | 1 | 0 | 3 |
| BPMC | BLUEPRINT MEDICINES CORP | 1,647,752 | $216.23K | 1 | 1 | 1 | 0 | 3 |
| CSTL | CASTLE BIOSCIENCES INC | 1,616,967 | $115.67K | 0 | 1 | 0 | 1 | 1 |
| ARCT | ARCTURUS THERAPEUTICS HOLDIN | 1,463,177 | $64.67K | 0 | 1 | 0 | 0 | 1 |
| CYH | COMMUNITY HEALTH SYSTEMS INC | 1,457,675 | $16.19K | 0 | 1 | 0 | 0 | 1 |
| DXCM | DEXCOM INC | 1,357,755 | $451.19K | 0 | 1 | 1 | 0 | 2 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,280,380 | $9.54K | 1 | 0 | 0 | 0 | 1 |
| MTNB | MATINAS BIOPHARMA HOLDINGS I | 1,219,162 | $1.66K | 1 | 0 | 0 | 0 | 1 |
| IONS | IONIS PHARMACEUTICALS INC | 1,175,175 | $84.35K | 0 | 1 | 1 | 0 | 2 |
| MCRB | SERES THERAPEUTICS INC | 1,172,413 | -$19.55K | 0 | 1 | 1 | 0 | 2 |
| WBA | WALGREENS BOOTS ALLIANCE INC | 1,151,862 | $51.35K | 0 | 3 | 0 | 1 | 4 |
| BEAM | BEAM THERAPEUTICS INC | 1,131,623 | $92.39K | 1 | 0 | 0 | 0 | 1 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 1,088,000 | $14.59K | 0 | 1 | 0 | 0 | 1 |
| ABT | ABBOTT LABORATORIES | 1,063,231 | $130.31K | 0 | 2 | 3 | 0 | 7 |
| BDX | BECTON DICKINSON AND CO | 982,234 | $445.18K | 4 | 6 | 4 | 0 | 15 |
| PHR | PHREESIA INC | 967,806 | $64.31K | 0 | 2 | 0 | 0 | 2 |
| GERN | GERON CORP | 961,624 | $1.53K | 0 | 1 | 0 | 0 | 1 |
| SENS | SENSEONICS HOLDINGS INC | 961,569 | $869 | 0 | 1 | 0 | 0 | 1 |
| ASND | ASCENDIS PHARMA A/S - ADR | 894,533 | $149.19K | 1 | 0 | 0 | 0 | 1 |
| DHR | DANAHER CORP | 890,015 | $262.88K | 0 | 2 | 4 | 1 | 9 |
| INCY | INCYTE CORP | 857,699 | $46.64K | 0 | 2 | 2 | 0 | 4 |
Frequently asked questions about Most bought healthcare stocks in Q4 2020
What are the most bought Healthcare stocks in Q4 2020?
The most bought healthcare stocks in Q4 2020 are those with the largest increase in reported share counts across tracked institutional investors compared to Q3 2020, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q4 2020?
Among the managers we track, net additions were largest in companies such as ABCELLERA BIOLOGICS INC (ABCL), VIATRIS INC (VTRS), BOSTON SCIENTIFIC CORP (BSX), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by tracked investors between two consecutive quarterly 13F snapshots (compared to Q3 2020).
Does this include all institutional owners?
These rankings are based on a subset of tracked institutional investors who file SEC 13F reports. While not exhaustive, the dataset includes many of the largest and most influential funds.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.